Anu Chawla/LinkedIn
Jun 29, 2026, 11:44
Anu Chawla: PICSI in Focus, What the HABSelect Trial Revealed?
Anu Chawla, Chairperson at Federation of obstetrics and Gynaecological Societies of India, shared a post on LinkedIn:
- The HABSelect Trial is the largest randomised study evaluating PICSI.
- It included 2,722 couples across 16 UK fertility centres.
- PICSI did not significantly improve overall live birth rates compared with standard ICSI.
- PICSI was associated with a lower miscarriage rate (14% vs 22%), representing approximately a 38% relative reduction.
- Current international guidelines do not recommend routine PICSI for every patient, but selected individuals may benefit.
- Treatment decisions should always be personalised following discussion with a fertility specialist.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jun 29, 2026, 12:34Fetal Interventions Course Offers Hands-On Training in London – GEFOG Health Foundation
-
Jun 29, 2026, 12:27Georges Raad: Presenting New Research on Stress and IVF Outcomes at ESHRE 2026
-
Jun 29, 2026, 12:23Luciana Chamie: Could Pelvic Varicose Veins Be the Hidden Cause of Chronic Pelvic Pain?
-
Jun 29, 2026, 11:57How It’s Changed Over the Years: HFEA to Discuss UK Fertility Regulation at ESHRE 2026 – HFEA
-
Jun 29, 2026, 11:54Marco Zaccaria: New FIGO Initiative Aims to Improve Fibroid Care Worldwide
-
Jun 29, 2026, 11:52How Teamwork Reduced Maternal and Newborn Deaths? – FIGO
-
Jun 29, 2026, 11:49Yinka Oyelese: Honored to Present at the World Congress of The Fetal Medicine Foundation!
-
Jun 29, 2026, 11:41Care Fertility and Birmingham City University Launch Advanced Fertility Ultrasound Module – Care Fertility
-
Jun 29, 2026, 11:34Vikram Sinai Talaulikar: Survey Reveals Major Gaps in Menopause Care for Cancer Survivors